Luteinizing hormone upregulates survivin and inhibits apoptosis in ovarian epithelial tumors

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 155, Issue 1, 2011, Pages 69-74

  Zhang, Zhenbo ^a   Liao, Hong ^b   Chen, Xiaojun ^c   Zheng, Yu ^c   Liu, Yingtao ^c   Tao, Xiang ^c   Gu, Chao ^c   Dong, Lingling ^b   Duan, Tao ^b   Yang, Yixia ^a   Liu, Xuelian ^a   Yu, Yinhua ^c   Feng, Youji ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Luteinizing hormone; Ovarian cancer; Survivin

Indexed keywords

CISPLATIN; LUTEINIZING HORMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; EPITHELIUM TUMOR; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 79952039003     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2010.10.017     Document Type: Article

References (36)

1. W.U. Gardner Tumorigenesis in transplanted irradiated and nonirradiated ovaries J Natl Cancer Inst 26 1961 829 853
2. B.V. Stadel Letter: the etiology and prevention of ovarian cancer Am J Obstet Gynecol 123 1975 772 774
3. A. Venn, L. Watson, F. Bruinsma, G. Giles, and D. Healy Risk of cancer after (Pubitemid 29515949)
4. C.T. Brekelmans Risk factors and risk reduction of breast and ovarian cancer Curr Opin Obstet Gynecol 15 2003 63 68 (Pubitemid 36143495)
5. C.H. Holschneider, and J.S. Berek Ovarian cancer: epidemiology, biology, and prognostic factors Semin Surg Oncol 19 2000 3 10 (Pubitemid 30439309)
6. A. Tavani, E. Ricci, and C. La Vecchia Influence of menstrual and reproductive factors on ovarian cancer risk in women with and without family history of breast or ovarian cancer Int J Epidemiol 29 2000 799 802
7. M. Daly, and G.I. Obrams Epidemiology and risk assessment for ovarian cancer Semin Oncol 25 1998 255 264 (Pubitemid 28272601)
8. S. Gnagy, E.E. Ming, S.S. Devesa, P. Hartge, and A.S. Whittemore Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use Epidemiology 11 2000 102 105 (Pubitemid 30112007)
9. W. Zheng, J.J. Lu, and F. Luo Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone Gynecol Oncol 76 2000 80 88 (Pubitemid 30048324)
10. C.M. Kurbacher, W. Jager, J.A. Kurbacher, A. Bittl, L. Wildt, and N. Lang Influence of human luteinizing hormone on cell growth and CA 125 secretion of primary epithelial ovarian carcinomas in vitro Tumour Biol 16 1995 374 384
11. H. Tashiro, K. Miyazaki, H. Okamura, A. Iwai, and M. Fukumoto c-myc over-expression in human primary ovarian tumours: its relevance to tumour progression Int J Cancer 50 1992 828 833
12. H. Kuroda, M. Mandai, and I. Konishi Human chorionic gonadotropin (hCG) inhibits cisplatin-induced apoptosis in ovarian cancer cells: possible role of up-regulation of insulin-like growth factor-1 by hCG Int J Cancer 76 1998 571 578 (Pubitemid 28228003)
13. D.E. Tourgeman, J.J. Lu, R. Boostanfar, C. Amezcua, J.C. Felix, and R.J. Paulson Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro Fertil Steril 78 2002 1096 1099 (Pubitemid 35292515)
14. J.H. Choi, K.C. Choi, N. Auersperg, and P.C. Leung Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells Cancer Res 66 2006 3912 3920
15. J.L. Tilly, K.I. Tilly, M.L. Kenton, and A.L. Johnson Expression of members of the bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-xlong messenger ribonucleic acid levels Endocrinology 136 1995 232 241
16. X. Chen, Z. Zhang, and Y. Feng Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistance Mod Pathol 22 2009 699 708
17. D.C. Altieri Survivin, versatile modulation of cell division and apoptosis in cancer Oncogene 22 2003 8581 8589 (Pubitemid 38019195)
18. Y. Huang, K. Hua, and X. Zhou Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma Cell Res 18 2008 780 791 (Pubitemid 351948227)
19. S. Bencini, M. Migaldi, and G. Castagnetti Apoptosis in prostate carcinoma before and after neoadjuvant therapy with LH-RH analog Ann N Y Acad Sci 1010 2003 789 792 (Pubitemid 38265083)
20. J.H. Choi, K.C. Choi, N. Auersperg, and P.C. Leung Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells Endocr Relat Cancer 12 2005 407 421 (Pubitemid 40896455)
21. S.K. Kang, C.J. Tai, K.W. Cheng, and P.C. Leung Gonadotropin-releasing hormone activates mitogen-activated protein kinase in human ovarian and placental cells Mol Cell Endocrinol 170 2000 143 151 (Pubitemid 32012587)
22. M.P. Luo, B. Gomperts, and S. Imren Establishment of long-term in vitro cultures of human ovarian cystadenomas and LMP tumors and examination of their spectrum of expression of matrix-degrading proteinases Gynecol Oncol 67 1997 277 284 (Pubitemid 28034634)
23. Z. Zhang, L. Jia, Y. Feng, and W. Zheng Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer Cancer Lett 278 2009 56 64
24. T. Riman, I. Persson, and S. Nilsson Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence Clin Endocrinol (Oxf) 49 1998 695 707 (Pubitemid 29009497)
25. C.F. Huang, D.Y. Liu, and K. Shen Follicle stimulating hormone inhibits cisplatin induced apoptosis in ovarian cancer cells Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25 2003 447 450
26. C.K. Lin, T.K. Chao, C.P. Yu, M.H. Yu, and J.S. Jin The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters APMIS 117 2009 162 175
27. J. Li, M. Xing, and M. Zhu Glycogen synthase kinase 3beta induces apoptosis in cancer cells through increase of survivin nuclear localization Cancer Lett 272 2008 91 101
28. Y. Kumazawa, K. Kawamura, and T. Sato HCG up-regulates survivin mRNA in human granulosa cells Mol Hum Reprod 11 2005 161 166 (Pubitemid 40662748)
29. C. Tang, Y.H. Lu, and J.H. Xie Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis Anticancer Drugs 20 2009 249 258
30. N. Zaffaroni, and M.G. Daidone Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions Drug Resist Updat 5 2002 65 72 (Pubitemid 35033448)
31. A.B. Als, L. Dyrskjot, and H. von der Maase Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer Clin Cancer Res 13 2007 4407 4414 (Pubitemid 47219707)
32. A.R. Hinnis, J.C. Luckett, and R.A. Walker Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients Br J Cancer 96 2007 639 645
33. Y. Nakagawa, S. Abe, and M. Kurata IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes Am J Hematol 81 2006 824 831 (Pubitemid 44682183)
34. R. Watanuki-Miyauchi, Y. Kojima, and H. Tsurumi Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B-cell lymphoma and its subtypes Pathol Int 55 2005 324 330 (Pubitemid 40910665)
35. E.J. Schlette, L.J. Medeiros, A. Goy, R. Lai, and G.Z. Rassidakis Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma J Clin Oncol 22 2004 1682 1688 (Pubitemid 41079807)
36. C. Adida, C. Haioun, and P. Gaulard Prognostic significance of survivin expression in diffuse large B-cell lymphomas Blood 96 2000 1921 1925 (Pubitemid 30661078)